TWIST1 and ovarian cancer: Meanwhile, another EMT-TF, Twist1, was recently identified as inducing DDR2 expression and ovarian cancer metastasis [21], suggesting that morphological changes by EMT-TFs might be a driving force for DDR2 expression and ovarian cancer progression.